NUDT19 overexpression and mTORC1 activator MYH1485 reversed the inhibitory effects of LINC00958 silencing on HCC proliferation, migration, and EMT process (Zuo et al., 2020; Lan et al., 2021). This evidence concerns the gene LINC00958 and hepatocellular carcinoma.